Your session is about to expire
← Back to Search
Health Insurance Literacy Intervention for Cancer Survivors (CHAT-S Trial)
N/A
Waitlist Available
Research Sponsored by University of Utah
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 18 months
Awards & highlights
CHAT-S Trial Summary
This trial will test a virtual health insurance intervention to help young adult cancer survivors ages 26-39 gain knowledge, reduce financial burden, and improve surveillance for recurrence. Cost-effectiveness and budget impact analyses will be used to measure sustainability.
Who is the study for?
This trial is for young adult cancer survivors aged 26 to 45, who have been treated for breast, testicular, lymphoma, sarcoma, or colorectal cancer within the last year. Participants must speak English and be patients at specific Utah healthcare institutions.Check my eligibility
What is being tested?
The study tests a virtual health insurance navigation program called CHAT-S against usual care. It aims to improve insurance knowledge, reduce financial stress and enhance monitoring for cancer recurrence in participants through four sessions.See study design
What are the potential side effects?
Since this intervention involves education and counseling rather than medical treatment, traditional physical side effects are not expected. However, participants may experience emotional or cognitive discomfort while discussing sensitive topics like finances and health.
CHAT-S Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 18 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~18 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
COmprehensive Score for financial Toxicity (COST)
Health Insurance Literacy Measure
Health Insurance Literacy Measure (HILM)
Secondary outcome measures
Acceptability
COVID-19 Health Care Impacts
Cost related literacy
+6 moreCHAT-S Trial Design
2Treatment groups
Experimental Treatment
Placebo Group
Group I: CHAT-SExperimental Treatment1 Intervention
CHAT-S consists of 4 bi-weekly 35-45 minute videoconferencing sessions with a patient navigator and a patient booklet on insurance, costs, and survivorship care.
Group II: Usual CarePlacebo Group1 Intervention
Usual care will consist of a resource list sent by the navigator.
Find a Location
Who is running the clinical trial?
University of UtahLead Sponsor
1,104 Previous Clinical Trials
1,782,233 Total Patients Enrolled
Intermountain HealthUNKNOWN
Massachusetts General HospitalOTHER
2,943 Previous Clinical Trials
13,200,689 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I finished my initial cancer treatment less than a year ago.I have been diagnosed with breast, testicular, lymphoma, sarcoma, or colorectal cancer.I speak English.I speak a language other than English.I cannot join via phone or video on a computer or mobile device.I am between 26 and 45 years old.
Research Study Groups:
This trial has the following groups:- Group 1: CHAT-S
- Group 2: Usual Care
Awards:
This trial has 0 awards, including:Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger